Topotecan    (DrugBank: Topotecan)

1 disease
IDDisease name (Link within this page)Number of trials
25Progressive multifocal leukoencephalopathy1

25. Progressive multifocal leukoencephalopathy    [ 23 clinical trials,   33 drugs,   (DrugBank: 20 drugs),   7 drug target genes,   36 drug target pathways]
Searched query = "Progressive multifocal leukoencephalopathy", "PML", "Leukoencephalopathy, progressive multifocal"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 23 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00002395
(ClinicalTrials.gov)
June 19962/11/1999Safety and Effectiveness of Topotecan HCl to Treat HIV-Infected Patients With AIDS-Related Progressive Multifocal Leukoencephalopathy (PML)An Open, Comparative Phase II Study of Immediate Versus Delayed Treatment With Topotecan HCl Given as a Continuous 21-Day Infusion Every 28 Days to Patients With AIDS-Related Progressive Multifocal LeukoencephalopathyHIV Infections;Leukoencephalopathy, Progressive MultifocalDrug: TopotecanSmithKline BeechamNULLCompleted18 YearsN/ABoth54Phase 2United States